bioRxivImmunologyPreprint
SARS-CoV-2 S protein activates the HIV latent reservoir through the mTOR pathway
Linle Xu, Liangjuan Chen, Hanying WangiD, Honglin Shi, Xingzhong Miao, Shiqing Li, Yue JiangiD, Hongbo Shi
Abstract
During the global COVID-19 pandemic, mRNA vaccines using the S protein as antigen were widely used.Vaccine-induced S proteins can persist in vivo for weeks, triggering low-level immune activation. HIV latent reservoir maintenance is a major challenge for ART therapy, especially when immune pressure is waning. This then raises critical questions for HIV-infected patients: does prolonged exposure to S proteins affect HIV latent reservoir stability? Recent studies have pointed out that S proteins may activate the mTOR signaling pathway, which in turn affects the immune response and metabolic processes of cells. And the mTOR pathway is closely related to the maintenance and activation of HIV latent reservoir. However, how S proteins affect the HIV latent reservoir and the mechanism of activation are unclear. To explore the mechanism of how SARS-CoV-2 S proteins regulate the HIV latent reservoir and to explore whether S proteins regulate the HIV latent reservoir through the mTOR pathway, we constructed an in vitro HIV latent reservoir model for our experiments.To evaluate the potential role of S protein in HIV latent reservoir activation, relevant markers of HIV latent reservoir activation were detected using ELISA, flow cytometry, and RT-qPCR; and the relationship between S protein and mTOR was also detected by WB, CO-IP, and IFC.It was found that S proteins activated the HIV latent reservoir while increasing mTOR expression. It was further observed that mTOR inhibitors significantly inhibited S protein-induced activation of the HIV latent reservoir, and mTOR activators reversed the inhibitory effect of mTOR inhibitors on HIV latent reservoir activation. In summary, we found that S proteins activated the HIV latent reservoir through the mTOR pathway. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=170 SRC="FIGDIR/small/670887v1_ufig1.gif" ALT="Figure 1"> View larger version (48K): org.highwire.dtl.DTLVardef@f6d87aorg.highwire.dtl.DTLVardef@1fe4cc0org.highwire.dtl.DTLVardef@60eefeorg.highwire.dtl.DTLVardef@1ea9a34_HPS_FORMAT_FIGEXP M_FIG S protein interacts with mTOR and activates the mTOR-p-p70S6K-pS6 pathway, which promotes HIV transcription C_FIG
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 S, M and E Structural Proteins Down-modulate HIV-1 LTR Activity and Modulate Endoplasmic Reticulum Stress Responses
Wejdan Oudah Albalawi, Jordan Thomas, … William A. Paxton·International Journal of Molecular SciencesPeer-reviewed·Jan 26, 2025
- The Envelope Protein of SARS-CoV-2 Inhibits Viral Protein Synthesis and Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)
E. B. Stephens, W. Henke, … M. Kalamvoki·bioRxiv·Mar 23, 2022
- Dysregulation in mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
S. Appelberg, S. Gupta, … U. Neogi·bioRxiv·Apr 30, 2020
- Adjuvants MPLA and SMNP induce antiviral immunity and indirectly revert HIV-1 latency
Jade Jansen, Killian E. Vlaming, … Neeltje A. Kootstra·PLoS ONEPeer-reviewed·Jul 20, 2026
- A new HIV-1 latency reversing agent activating HIV-Tat
Phuoc Bao Viet Tong, Laetitia Marty, … Bruno D. Beaumelle·bioRxiv·Aug 21, 2026
- Inhibitor of apoptosis, IAP, genes play a critical role in the survival of HIV-infected macrophages
A. Kumar, R. E. H. Caballero, … J. Angel·bioRxiv·Feb 6, 2019